---
layout: post
title: "917 hz - Rife Frequency"
description: "Comprehensive scientific analysis of 917 Hz Rife frequency: resonance models for kidney papilloma and renal papillary neoplasms."
subject: "917 hz - Rife Frequency"
apple-title: "917 hz - Rife Frequency"
app-name: "917 hz - Rife Frequency"
tweet-title: "917 hz - Rife Frequency"
tweet-description: "Comprehensive scientific analysis of 917 Hz Rife frequency: resonance models for kidney papilloma and renal papillary neoplasms."
date: 2024-12-28
keywords: "frequency benefits, Brain Beats Pro, Frequencies, brainwave entrainment, sound therapy, 917 hz, rife frequency, kidney papilloma, papilloma kidney, renal pelvis papilloma, papillary renal neoplasm, urothelial tumor, hematuria, CAFL frequencies"
---

The **917 Hz Rife Frequency** is a renal resonance node cataloged for **Kidney papilloma** and the reversed-order entry **Papilloma kidney**, two spellings for the same papillary renal lesion. Located at approximately **A#/Bb5 (-28.7 cents)** relative to concert pitch $A_4 = 440\text{ Hz}$, it is cataloged in the Consolidated Annotated Frequency List (CAFL) for **Kidney papilloma** and **Papilloma kidney**.

---

### 1. Microbiological & Pathological Profile

- **Urothelial Papilloma**: A rare benign papillary tumor of the renal pelvis or calyx. It is made of delicate fibrovascular cores covered by normal-appearing urothelium and is closely related to papillary urothelial neoplasms that can progress.
- **Papillary Renal Adenoma**: A small (under 15 mm) well-circumscribed cortical lesion with papillary or tubular architecture. It is common as an incidental autopsy finding and is related to papillary renal cell carcinoma.
- **Related Malignancies**: Papillary renal cell carcinoma (type 1 often has *MET* alterations) and urothelial carcinoma of the renal pelvis share overlapping imaging and clinical features with benign papillary lesions, so tissue diagnosis matters.
- **Presentation and Work-up**: Painless gross hematuria is the classic sign. Evaluation uses CT urography, ureteroscopy with biopsy and urine cytology. Management is surgical (nephron-sparing or nephroureterectomy depending on pathology).

---

### 2. Biophysical Mechanism of Action

```
+-----------------------------------------------------------------------------------------+
|                                917 Hz MECHANISM OF ACTION                               |
+-----------------------------------------------------------------------------------------+
                                             |
                      Acoustic Longitudinal Compression Wave (917 Hz)
                                             |
[Renal Parenchyma]               [Renal Perfusion]                [Autonomic State]
|                                |                                |
Pressure Wave Transmission       Vascular Shear Stimulus          Relaxation Response
|                                |                                |
Micro-Vibration of Tissue        Enhanced Circulation             Lower Sympathetic Tone
                                             |
                               Proposed Downstream Outcomes:
   * Modeling of low-frequency transmission into the flank
   * Possible perfusion support
   * Relaxation during diagnostic follow-up
```

#### Resonance Breakdown
1. **Penetration Depth**: Soft-tissue attenuation is roughly $\alpha \approx 0.5\text{ dB cm}^{-1}\text{ MHz}^{-1}$, so at $917\text{ Hz}$ the loss is about $4.6\times 10^{-4}\text{ dB/cm}$, which is negligible. The wavelength $\lambda = c/f_0 \approx 1.68\text{ m}$ is much longer than the kidney (~11 cm), so the field is nearly uniform across the organ and cannot be focused on a small lesion.
2. **Interpretive Limit**: Because the tissue field is uniform and weak, no mechanical selectivity for a papillary lesion exists. Any effect would be systemic (relaxation, perfusion), not lesion-specific.

> [!NOTE]
> These mechanisms are theoretical models. No controlled clinical trial has shown that audible-frequency sound treats the conditions described here.

---

### 3. Harmonic Hierarchy & Resonance Tree

```
[114.62 Hz] <--- [229.25 Hz] <--- [458.50 Hz] <--- [917 Hz] ---> [1834.00 Hz] ---> [2751.00 Hz] ---> [3668.00 Hz]
Autonomic   Lymphatic   Renal   Master   Parenchymal   Vascular   Broad
```

- **Fundamental ($f_0$)**: 917 Hz, the primary resonance driver for this preset.
- **Sub-Harmonic ($f_{-1} = 458.5\text{ Hz}$)**: Supports renal and splanchnic perfusion.
- **Sub-Harmonic ($f_{-2} = 229.25\text{ Hz}$)**: Supports retroperitoneal lymphatic flow.
- **Harmonic ($2f_0 = 1834\text{ Hz}$)**: Second-order overtone for parenchymal vibration.
- **Harmonic ($3f_0 = 2751\text{ Hz}$)**: Third-order overtone for vascular shear stimulation.

---

### 4. Practical Session Parameters

| Parameter | Recommended Specification | Research Objective |
| :--- | :--- | :--- |
| **Delivery Medium** | Circumaural headphones or contact pad on the flank | Even, low-distortion acoustic delivery |
| **Waveform Dynamic** | Pure sine wave with gentle 0.1 Hz amplitude modulation | Avoids sensory adaptation during extended sessions |
| **Exposure Schedule** | 20 to 30 minutes once daily | Matches the biological timescale of the condition |
| **Supportive Regimen** | Hydration (unless restricted), urology follow-up and imaging surveillance | Supports recovery; does not replace standard medical care |

> **Interactive Sound Laboratory:** Experience the **917 Hz** frequency live on the **[Brain Beats Pro Pure Tone Generator](/pure-tone-generator.html)**, test multi-wave entrainment with the **[Binaural Beats Generator](/binaural-beats-generator.html)**, or cross-reference complementary targets in the **[Rife Frequencies CAFL Directory](/rife-frequencies-cafl-xref.html)**.
>
> **Medical Disclaimer:** The vibrational protocols discussed herein are intended for scientific modeling, psychoacoustic research, and complementary sound therapy. They do not constitute medical diagnosis, clinical advice, or treatment. Blood in the urine (even once) requires urgent evaluation by a urologist, because it can signal malignancy. Always consult licensed healthcare practitioners for medical concerns.

---

### 5. Web Audio API Master Synthesizer

```javascript
/**
 * Rife917Synthesizer - Web Audio API Synthesis Engine for 917 Hz
 * Calibrated for the 917 Hz kidney papilloma preset.
 */
class Rife917Synthesizer {
  constructor() {
    this.audioCtx = null;
    this.carrier = null;
    this.subOctave = null;
    this.masterGain = null;
    this.isActive = false;
  }

  init() {
    const AudioCtx = window.AudioContext || window.webkitAudioContext;
    this.audioCtx = new AudioCtx();

    this.masterGain = this.audioCtx.createGain();
    this.masterGain.gain.setValueAtTime(0.0001, this.audioCtx.currentTime);
    this.masterGain.connect(this.audioCtx.destination);
  }

  start(durationMinutes = 30) {
    if (!this.audioCtx) this.init();
    if (this.isActive) return;

    const t = this.audioCtx.currentTime;

    // 917 Hz primary carrier
    this.carrier = this.audioCtx.createOscillator();
    this.carrier.type = 'sine';
    this.carrier.frequency.setValueAtTime(917, t);

    // 458.5 Hz sub-harmonic
    this.subOctave = this.audioCtx.createOscillator();
    this.subOctave.type = 'sine';
    this.subOctave.frequency.setValueAtTime(458.5, t);

    const subGain = this.audioCtx.createGain();
    subGain.gain.setValueAtTime(0.22, t);

    this.carrier.connect(this.masterGain);
    this.subOctave.connect(subGain);
    subGain.connect(this.masterGain);

    // Smooth attack ramp
    this.masterGain.gain.exponentialRampToValueAtTime(0.3, t + 3);

    this.carrier.start(t);
    this.subOctave.start(t);
    this.isActive = true;

    // Scheduled session shutdown
    const stopTime = t + (durationMinutes * 60);
    this.masterGain.gain.setValueAtTime(0.3, stopTime - 3);
    this.masterGain.gain.exponentialRampToValueAtTime(0.0001, stopTime);
    this.carrier.stop(stopTime);
    this.subOctave.stop(stopTime);

    this.carrier.onended = () => {
      this.isActive = false;
    };
  }

  stop() {
    if (!this.isActive || !this.audioCtx) return;
    const t = this.audioCtx.currentTime;
    this.masterGain.gain.linearRampToValueAtTime(0.0001, t + 1);
    setTimeout(() => {
      if (this.carrier) this.carrier.stop();
      if (this.subOctave) this.subOctave.stop();
      this.isActive = false;
    }, 1000);
  }
}

// Example usage:
// const session = new Rife917Synthesizer();
// document.getElementById('btnStart').addEventListener('click', () => session.start(30));
```

---

### 6. Summary & Academic Citations

The **917 Hz Rife Frequency** is a CAFL entry for papillary renal lesions. The acoustic physics shows no lesion-specific action, so it is presented only as a relaxation modeling reference.

1. **Moch, H., et al.** (2016). *The 2016 WHO classification of tumours of the urinary system and male genital organs, Part A: renal, penile, and testicular tumours*. European Urology, 70(1), 93-105.
2. **Linehan, W. M., et al.** (2016). *Comprehensive molecular characterization of papillary renal-cell carcinoma*. New England Journal of Medicine, 374(2), 135-145.
3. **Roupret, M., et al.** (2021). *European Association of Urology guidelines on upper urinary tract urothelial carcinoma*. European Urology, 79(1), 62-79.
4. **Duck, F. A.** (1990). *Physical Properties of Tissue: A Comprehensive Reference Book*. Academic Press.

---

<div align="center">
<sub>&copy; Brain Beats Pro. Written content and research documentation are licensed under <a href="/licenses.html" rel="license">CC BY 4.0</a>. Web Audio synthesis mechanics and source code are copyleft protected under <a href="/licenses.html">GNU AGPLv3</a>.</sub>
</div>
